1983
DOI: 10.1007/978-3-642-69460-8_8
|View full text |Cite
|
Sign up to set email alerts
|

Antibodies to Synthetic Peptides Targeted to the Transforming Genes of Human Adenoviruses: An Approach to Understanding Early Viral Gene Function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1985
1985
1996
1996

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 103 publications
0
3
0
Order By: Relevance
“…The E1B 19 kDa protein is expressed within the first 10 h post-infection (Green et al, 1983;Wold and Gooding, 1991;Akusjä rvi, 1993). We therefore speculate that it might be especially important for the virus to counteract NF-B activity early in the course of the viral infection in order to escape an antiviral response.…”
Section: Discussionmentioning
confidence: 99%
“…The E1B 19 kDa protein is expressed within the first 10 h post-infection (Green et al, 1983;Wold and Gooding, 1991;Akusjä rvi, 1993). We therefore speculate that it might be especially important for the virus to counteract NF-B activity early in the course of the viral infection in order to escape an antiviral response.…”
Section: Discussionmentioning
confidence: 99%
“…human 81-globin and e-globin genes (Allan et al, 1984). However, analysis of the effect of adenovirus E1A on several host cell genes, including the genes for pre-proinsulin and globins, suggests that stimulatory activity is restricted to newlyintroduced genes, and does not occur with endogenous class II genes (Babich et al, 1983;Gaynor et al, 1984;Green et al, 1983). This also applies to genes transcribed by polymerase III.…”
Section: Experimental Approachesmentioning
confidence: 99%
“…Procedures for solid-phase peptide synthesis, peptide coupling to keyhole limpet hemocyanin, and rabbit (New Zealand White) immunization were essentially as described previously (20). The anti-peptide antiserum (3 ,ul) and in some cases anti-BLV antiserum (5 ,ul) (4).…”
Section: Methodsmentioning
confidence: 99%